Applied Financial Statements From 2010 to 2024

AGTCDelisted Stock  USD 0.39  0.00  0.00%   
Applied Genetic financial statements provide useful quarterly and yearly information to potential Applied Genetic investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Applied Genetic financial statements helps investors assess Applied Genetic's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Applied Genetic's valuation are summarized below:
Applied Genetic does not presently have any fundamental signals for analysis.
Check Applied Genetic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Applied main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Applied financial statements analysis is a perfect complement when working with Applied Genetic Valuation or Volatility modules.
  
This module can also supplement various Applied Genetic Technical models . Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

Applied Genetic Company Shares Outstanding Analysis

Applied Genetic's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Applied Genetic Shares Outstanding

    
  67.63 M  
Most of Applied Genetic's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Applied Genetic is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, Applied Genetic has 67.63 M of shares currently outstending. This is 62.54% lower than that of the Biotechnology sector and 36.71% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 88.17% higher than that of the company.

Applied Genetic Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Applied Genetic's current stock value. Our valuation model uses many indicators to compare Applied Genetic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Applied Genetic competition to find correlations between indicators driving Applied Genetic's intrinsic value. More Info.
Applied Genetic is rated fifth in return on equity category among related companies. It is number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Applied Genetic by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Applied Genetic's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Applied Genetic's earnings, one of the primary drivers of an investment's value.

About Applied Genetic Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Applied Genetic income statement, its balance sheet, and the statement of cash flows. Applied Genetic investors use historical funamental indicators, such as Applied Genetic's revenue or net income, to determine how well the company is positioned to perform in the future. Although Applied Genetic investors may use each financial statement separately, they are all related. The changes in Applied Genetic's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Applied Genetic's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Applied Genetic Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Applied Genetic. Please read more on our technical analysis and fundamental analysis pages.
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company was incorporated in 1999 and is headquartered in Alachua, Florida. Applied Genetic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 102 people.

Pair Trading with Applied Genetic

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Applied Genetic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied Genetic will appreciate offsetting losses from the drop in the long position's value.

Moving against Applied Stock

  0.46BA Boeing Earnings Call TomorrowPairCorr
  0.45MRK Merck Company Earnings Call This WeekPairCorr
The ability to find closely correlated positions to Applied Genetic could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Applied Genetic when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Applied Genetic - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Applied Genetic to buy it.
The correlation of Applied Genetic is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Applied Genetic moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Applied Genetic moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Applied Genetic can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Consideration for investing in Applied Stock

If you are still planning to invest in Applied Genetic check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Applied Genetic's history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine